Your browser doesn't support javascript.
loading
New Mechanisms of Resistance to MEK Inhibitors in Melanoma Revealed by Intravital Imaging.
Brighton, Hailey E; Angus, Steven P; Bo, Tao; Roques, Jose; Tagliatela, Alicia C; Darr, David B; Karagoz, Kubra; Sciaky, Noah; Gatza, Michael L; Sharpless, Norman E; Johnson, Gary L; Bear, James E.
Afiliación
  • Brighton HE; UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Angus SP; Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Bo T; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Roques J; UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Tagliatela AC; UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Darr DB; UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Karagoz K; Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Sciaky N; UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Gatza ML; Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
  • Sharpless NE; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Johnson GL; Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
  • Bear JE; UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Cancer Res ; 78(2): 542-557, 2018 01 15.
Article en En | MEDLINE | ID: mdl-29180473

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piridonas / Pirimidinonas / Biomarcadores de Tumor / Resistencia a Antineoplásicos / MAP Quinasa Quinasa 1 / Inhibidores de Proteínas Quinasas / Microscopía Intravital / Melanoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Cancer Res Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piridonas / Pirimidinonas / Biomarcadores de Tumor / Resistencia a Antineoplásicos / MAP Quinasa Quinasa 1 / Inhibidores de Proteínas Quinasas / Microscopía Intravital / Melanoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Cancer Res Año: 2018 Tipo del documento: Article